In vitro experiments showed that these cells display a strongly reduced capacity to kill PD-L+ tumor cells as well as impaired release of interferon-γ (IFN-γ) and tumor necrosis factor-α (TNF-α) cytokines after stimulation with the same PD-L+ tumor targets. This evidence concerns the gene IFNG and neoplasm.